191 related articles for article (PubMed ID: 22074621)
1. Cellular therapies supplement: the peritoneum as an ectopic site of hematopoiesis following in utero transplantation.
Muench MO; Chen JC; Beyer AI; Fomin ME
Transfusion; 2011 Nov; 51 Suppl 4(Suppl 4):106S-117S. PubMed ID: 22074621
[TBL] [Abstract][Full Text] [Related]
2. Persistence of allografts in the peritoneal cavity after prenatal transplantation in mice.
Chen JC; Chang ML; Muench MO
Transfusion; 2008 Mar; 48(3):553-60. PubMed ID: 18067493
[TBL] [Abstract][Full Text] [Related]
3. Development of either split tolerance or robust tolerance along with humoral tolerance to donor and third-party alloantigens in nonmyeloablative mixed chimeras.
Chan WF; Razavy H; Luo B; Shapiro AM; Anderson CC
J Immunol; 2008 Apr; 180(8):5177-86. PubMed ID: 18390699
[TBL] [Abstract][Full Text] [Related]
4. Induction of tolerance in nondefective mice after in utero transplantation of major histocompatibility complex-mismatched fetal hematopoietic stem cells.
Carrier E; Lee TH; Busch MP; Cowan MJ
Blood; 1995 Dec; 86(12):4681-90. PubMed ID: 8541562
[TBL] [Abstract][Full Text] [Related]
5. A nonlethal conditioning approach to achieve durable multilineage mixed chimerism and tolerance across major, minor, and hematopoietic histocompatibility barriers.
Colson YL; Wren SM; Schuchert MJ; Patrene KD; Johnson PC; Boggs SS; Ildstad ST
J Immunol; 1995 Nov; 155(9):4179-88. PubMed ID: 7594573
[TBL] [Abstract][Full Text] [Related]
6. Long-Term Hematopoietic Engraftment of Congenic Amniotic Fluid Stem Cells After in Utero Intraperitoneal Transplantation to Immune Competent Mice.
Shangaris P; Loukogeorgakis SP; Blundell MP; Petra E; Shaw SW; Ramachandra DL; Maghsoudlou P; Urbani L; Thrasher AJ; De Coppi P; David AL
Stem Cells Dev; 2018 Apr; 27(8):515-523. PubMed ID: 29482456
[TBL] [Abstract][Full Text] [Related]
7. The use of CD 34(+) mobilized peripheral blood as a donor cell source does not improve chimerism after in utero hematopoietic stem cell transplantation in non-human primates.
Shields LE; Gaur L; Delio P; Gough M; Potter J; Sieverkropp A; Andrews RG
J Med Primatol; 2005 Aug; 34(4):201-8. PubMed ID: 16053498
[TBL] [Abstract][Full Text] [Related]
8. Mixed chimerism induces donor-specific T-cell tolerance across a highly disparate xenogeneic barrier.
Abe M; Qi J; Sykes M; Yang YG
Blood; 2002 May; 99(10):3823-9. PubMed ID: 11986242
[TBL] [Abstract][Full Text] [Related]
9. Prenatal tolerance induction: relationship between cell dose, marrow T-cells, chimerism, and tolerance.
Chen JC; Chang ML; Huang SF; Chang PY; Muench MO; Fu RH; Ou LS; Kuo ML
Cell Transplant; 2008; 17(5):495-506. PubMed ID: 18714669
[TBL] [Abstract][Full Text] [Related]
10. Hematopoietic cell transplantation for the induction of allo- and xenotolerance.
Sykes M
Clin Transplant; 1996 Aug; 10(4):357-63. PubMed ID: 8884109
[TBL] [Abstract][Full Text] [Related]
11. Stable long-term mixed chimerism achieved in a canine model of allogeneic in utero hematopoietic cell transplantation.
Vrecenak JD; Pearson EG; Santore MT; Todorow CA; Li H; Radu A; Bhatti T; Peranteau WH; Johnson MP; Flake AW
Blood; 2014 Sep; 124(12):1987-95. PubMed ID: 24869940
[TBL] [Abstract][Full Text] [Related]
12. In utero hematopoietic stem cell transplantation: progress toward clinical application.
Merianos D; Heaton T; Flake AW
Biol Blood Marrow Transplant; 2008 Jul; 14(7):729-40. PubMed ID: 18541191
[TBL] [Abstract][Full Text] [Related]
13. Complete allogeneic hematopoietic chimerism achieved by a combined strategy of in utero hematopoietic stem cell transplantation and postnatal donor lymphocyte infusion.
Hayashi S; Peranteau WH; Shaaban AF; Flake AW
Blood; 2002 Aug; 100(3):804-12. PubMed ID: 12130490
[TBL] [Abstract][Full Text] [Related]
14. Characterization of tolerance induction through prenatal marrow transplantation: the requirement for a threshold level of chimerism to establish rather than maintain postnatal skin tolerance.
Chen JC; Kuo ML; Ou LS; Chang PY; Muench MO; Shen CR; Chang HL; Yu HY; Fu RH
Cell Transplant; 2010; 19(12):1609-22. PubMed ID: 20719075
[TBL] [Abstract][Full Text] [Related]
15. Prolonged survival of mouse skin allografts after transplantation of fetal liver cells transduced with hIL-10 gene.
Sembeil R; Sanhadji K; Vivier G; Chargui J; Touraine JL
Transpl Immunol; 2004; 13(1):1-8. PubMed ID: 15203122
[TBL] [Abstract][Full Text] [Related]
16. Effect of selective T cell depletion of host and/or donor bone marrow on lymphopoietic repopulation, tolerance, and graft-vs-host disease in mixed allogeneic chimeras (B10 + B10.D2----B10).
Ildstad ST; Wren SM; Bluestone JA; Barbieri SA; Stephany D; Sachs DH
J Immunol; 1986 Jan; 136(1):28-33. PubMed ID: 2933464
[TBL] [Abstract][Full Text] [Related]
17. Mixed allogeneic reconstitution (A+B----A) to induce donor-specific transplantation tolerance. Permanent acceptance of a simultaneous donor skin graft.
Ildstad ST; Wren SM; Oh E; Hronakes ML
Transplantation; 1991 Jun; 51(6):1262-7. PubMed ID: 1828637
[TBL] [Abstract][Full Text] [Related]
18. Microchimerism does not induce tolerance and sustains immunity after in utero transplantation.
Donahue J; Gilpin E; Lee TH; Busch MP; Croft M; Carrier E
Transplantation; 2001 Feb; 71(3):359-68. PubMed ID: 11233894
[TBL] [Abstract][Full Text] [Related]
19. Alloreactivity following in utero transplantation of cytokine-stimulated hematopoietic stem cells: the role of recipient CD4(-) cells.
Sefrioui H; Donahue J; Srivastava AS; Gilpin E; Lee TH; Carrier E
Exp Hematol; 2002 Jun; 30(6):617-24. PubMed ID: 12063030
[TBL] [Abstract][Full Text] [Related]
20. Stable mixed hematopoietic chimerism permits tolerance of vascularized composite allografts across a full major histocompatibility mismatch in swine.
Mathes DW; Solari MG; Gazelle GS; Butler PE; Wu A; Nazzal A; Nielsen GP; Huang CA; Sachs DH; Lee WP; Randolph MA
Transpl Int; 2014 Oct; 27(10):1086-96. PubMed ID: 24963743
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
